Inventor
Achim H. Krauss
Inventor
Foothill Ranch, CA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
C07CAcyclic or carbocyclic compounds7%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
A61QSpecific use of cosmetics or similar toiletry preparations2%
PatentTitleYear
10,751,334Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions202010,413,535Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditions20198,101,658'Nitric oxide donating prostamides'20127,718,656'Prostaglandin derivatives'20107,612,082'Prostaglandin EP4 antagonists'20097,273,883'Prostaglandin EP4 antagonist'20077,217,725'Prostaglandin D2 antagonist'20077,070,768'Method for imparting artificial tan to human skin'20067,045,634'Prostamide receptor antagonists'20067,019,149'Thromboxane ligands without blood clotting side effects'20066,956,057'EP4 agonists as agents for lowering intraocular pressure'20056,818,779'Thromboxane ligands without blood clotting side effects'20046,713,268'Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation'20046,462,077'Thromboxane ligands without blood clotting side effects'20026,395,787'Ocular hypotensive lipids'20026,090,845'Thromboxane ligands'20006,017,953'Thromboxane ligands'20005,741,812'Thromboxane ligands without blood clotting side effects'19985,652,236'Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors'19975,650,431'Thromboxane ligands without blood clotting side effects'19975,602,143'Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors'19975,516,791'7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereof'19965,416,106'7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2009Patents assigned to ALLERGAN INC (16)· patent assignee history
1995–1997Based in Irvine, CA, US· patent location history
1997–2007Based in Foothill Ranch, CA, US· patent location history
2000–2002Patents assigned to ALLERGAN SALES INC (3)· patent assignee history
2006–2020Based in San Marcos, CA, US· patent location history
2010–2012Patents assigned to NICOX SA (2)· patent assignee history
2012Patents assigned to BENEDINI FRANCESCA (1)· patent assignee history
2019–2020Patents assigned to AXEROVISION INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALLERGAN INC | 16 | 1995–2009 |
| ALLERGAN SALES INC | 3 | 2000–2002 |
| AXEROVISION INC | 2 | 2019–2020 |
| NICOX SA | 2 | 2010–2012 |
| BENEDINI FRANCESCA | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Foothill Ranch, California, US | 13 | 1997–2007 |
| San Marcos, California, US | 7 | 2006–2020 |
| Irvine, California, US | 3 | 1995–1997 |